COVID-19 and Thrombosis: Pathophysiological Mechanisms and Therapeutic Update
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a pro-inflammatory and prothrombogenic virus with a high mutagenic profile, which produces active infection of variable duration in various organs and systems, and it has been observed that patients who have already suffered from the di...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2022
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/81047 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: COVID-19 and Thrombosis: Pathophysiological Mechanisms and Therapeutic Update
- The Renin-Angiotensin-Aldosterone System: Mechanisms, Pathophysiological Impacts, and Emerging Therapeutic Strategies
- Pathophysiology of Gastric Ulcer Development and Healing: Molecular Mechanisms and Novel Therapeutic Options
- Anaphylactic shock: a review of the pathophysiology and therapeutic management
- Role of Ferroptosis in AML Pathophysiology and Therapeutic Strategies
- Diabetic Cardiomyopathy: Cardiac Changes, Pathophysiological Mechanisms, Biologic Markers, and the Available Therapeutic Armamentarium
- COVID-19: From Pathophysiology to Treatment